Cargando…

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

Parkinson plus diseases, comprising mainly progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are rare neurodegenerative conditions. We designed a double-blind randomized placebo-controlled trial of riluzole as a potential disease-modifying agent in Parkinson plus disorders (NNIP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bensimon, Gilbert, Ludolph, Albert, Agid, Yves, Vidailhet, Marie, Payan, Christine, Leigh, P. Nigel
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638696/ https://www.ncbi.nlm.nih.gov/pubmed/19029129 http://dx.doi.org/10.1093/brain/awn291

Ejemplares similares

Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE
por: Payan, Christine A. M., et al.
Publicado: (2011)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
por: Fang, Ton, et al.
Publicado: (2018)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability
por: Rolland, Yan, et al.
Publicado: (2011)

Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy
por: Al-Chalabi, Ammar, et al.
Publicado: (2009)

Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation
por: Lau, Brian, et al.
Publicado: (2019)

Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis
por: Thakore, Nimish J., et al.
Publicado: (2022)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
por: Üstün Bezgin, Selin, et al.
Publicado: (2019)

Riluzole: Interstitial pneumonia: case report
Publicado: (2022)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
por: Carbone, Marica, et al.
Publicado: (2012)

Riluzole Ameliorates Harmaline-induced Tremor in Rat
por: Shourmasti, Fatemeh Rahimi, et al.
Publicado: (2014)

Stability-indicating Method for the Estimation of Riluzole in Tablets
por: Neeha, T., et al.
Publicado: (2013)

N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
por: Kim, Jaejeong, et al.
Publicado: (2023)

Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway
por: Vallée, Alexandre, et al.
Publicado: (2020)

Pharmacological investigation of memory restorative effect of riluzole in mice
por: Rinwa, Puneet, et al.
Publicado: (2012)

Riluzole Stimulates BDNF Release from Human Platelets
por: Türck, Patrick, et al.
Publicado: (2015)

Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives
por: Wu, Xiang-Long, et al.
Publicado: (2020)

Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
por: Rokade, Aditi V, et al.
Publicado: (2022)

Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film
por: Wymer, James, et al.
Publicado: (2022)

Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole
por: Liao, Sally, et al.
Publicado: (2017)

Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
por: Marsili, Luca, et al.
Publicado: (2018)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna, Alessandro, et al.
Publicado: (2018)

Analysis of riluzole’s profile of use in a Central Hospital in Lisbon
por: Paróla, Ana, et al.
Publicado: (2018)

Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review
por: Ayala, Iván Nicolas, et al.
Publicado: (2022)

Structural identification of riluzole-binding site on human TRPC5
por: Yang, Yaxiong, et al.
Publicado: (2022)

Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases
por: Llorente, Xavier, et al.
Publicado: (2023)

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
por: Hinchcliffe, Michael, et al.
Publicado: (2017)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

Riluzole prevents stress-induced spine plasticity in the hippocampus but mimics it in the amygdala
por: Naskar, Saptarnab, et al.
Publicado: (2022)

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis
por: Mazumder, Srestha, et al.
Publicado: (2022)

A randomized controlled phase II trial of riluzole in early multiple sclerosis
por: Waubant, Emmanuelle, et al.
Publicado: (2014)

Computational Insights into The Neuroprotective Action of Riluzole on 3-Acetylpyridine-Induced Ataxia in Rats
por: Abbasi, Samira, et al.
Publicado: (2013)

The antioxidant effects of riluzole on the APRE-19 celll model injury-induced by t-BHP
por: Shen, Chaolan, et al.
Publicado: (2017)

Riluzole as a Neuroprotective Drug for Spinal Cord Injury: From Bench to Bedside
por: Nagoshi, Narihito, et al.
Publicado: (2015)

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
por: Jayaprakash, Kiran, et al.
Publicado: (2020)

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
por: Xu, Qifu, et al.
Publicado: (2020)

Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
por: Benavides-Serrato, Angelica, et al.
Publicado: (2020)

Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer
por: Olukoya, Ayodeji O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llv1s9rfp55h7iqlrp6ro0gcmo